Follow
Dahlene Fusco
Dahlene Fusco
Tulane University School of Medicine
Verified email at tulane.edu
Title
Cited by
Cited by
Year
Single mRNA molecules demonstrate probabilistic movement in living mammalian cells
D Fusco, N Accornero, B Lavoie, SM Shenoy, JM Blanchard, RH Singer, ...
Current Biology 13 (2), 161-167, 2003
6862003
Dynamics of single mRNPs in nuclei of living cells
Y Shav-Tal, X Darzacq, SM Shenoy, D Fusco, SM Janicki, DL Spector, ...
science 304 (5678), 1797-1800, 2004
5532004
Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis
Z Huang, D Tian, Y Liu, Z Lin, CJ Lyon, W Lai, D Fusco, A Drouin, X Yin, ...
Biosensors and Bioelectronics 164, 112316, 2020
3072020
IL28B inhibits hepatitis C virus replication through the JAK–STAT pathway
L Zhang, N Jilg, RX Shao, W Lin, DN Fusco, H Zhao, K Goto, LF Peng, ...
Journal of hepatology 55 (2), 289-298, 2011
1602011
Kinetic differences in the induction of interferon stimulated genes by interferon‐α and interleukin 28B are altered by infection with hepatitis C virus
N Jilg, W Lin, J Hong, EA Schaefer, D Wolski, J Meixong, K Goto, C Brisac, ...
Hepatology 59 (4), 1250-1261, 2014
1182014
Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling
K Kumthip, P Chusri, N Jilg, L Zhao, DN Fusco, H Zhao, K Goto, D Cheng, ...
Journal of virology 86 (16), 8581-8591, 2012
972012
Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized …
MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ...
Jama 327 (5), 432-441, 2022
932022
Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection
DS Fierer, DT Dieterich, MI Fiel, AD Branch, KM Marks, DN Fusco, R Hsu, ...
Clinical infectious diseases 56 (7), 1038-1043, 2013
882013
HCV induces transforming growth factor β1 through activation of endoplasmic reticulum stress and the unfolded protein response
P Chusri, K Kumthip, J Hong, C Zhu, X Duan, N Jilg, DN Fusco, C Brisac, ...
Scientific reports 6 (1), 22487, 2016
702016
A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus
H Zhao, W Lin, K Kumthip, D Cheng, DN Fusco, O Hofmann, N Jilg, ...
Journal of hepatology 56 (2), 326-333, 2012
642012
Echinacea purpurea aerial extract alters course of influenza infection in mice
D Fusco, X Liu, C Savage, Y Taur, W Xiao, E Kennelly, J Yuan, ...
Vaccine 28 (23), 3956-3962, 2010
582010
Novel therapies for hepatitis C: insights from the structure of the virus
DN Fusco, RT Chung
Annual review of medicine 63, 373-387, 2012
532012
A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication
DN Fusco, C Brisac, SP John, YW Huang, CR Chin, T Xie, H Zhao, N Jilg, ...
Gastroenterology 144 (7), 1438-1449. e9, 2013
502013
EFTUD2 is a novel innate immune regulator restricting hepatitis C virus infection through the RIG-I/MDA5 pathway
C Zhu, F Xiao, J Hong, K Wang, X Liu, D Cai, DN Fusco, L Zhao, ...
Journal of virology 89 (13), 6608-6618, 2015
482015
MicroRNA 130a regulates both hepatitis C virus and hepatitis B virus replication through a central metabolic pathway
X Duan, S Li, JA Holmes, Z Tu, Y Li, D Cai, X Liu, W Li, C Yang, B Jiao, ...
Journal of virology 92 (7), 10.1128/jvi. 02009-17, 2018
412018
Exposure to human immunodeficiency virus/hepatitis C virus in hepatic and stellate cell lines reveals cooperative profibrotic transcriptional activation between viruses and …
S Salloum, JA Holmes, R Jindal, SS Bale, C Brisac, N Alatrakchi, ...
Hepatology 64 (6), 1951-1968, 2016
412016
The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling
K Goto, W Lin, L Zhang, N Jilg, RX Shao, EAK Schaefer, H Zhao, ...
Journal of Hepatology 59 (5), 942-948, 2013
402013
Emergence of an early SARS-CoV-2 epidemic in the United States
M Zeller, K Gangavarapu, C Anderson, AR Smither, JA Vanchiere, ...
Cell 184 (19), 4939-4952. e15, 2021
392021
SARS-CoV-2 variant vaccine boosters trial: preliminary analyses
AR Branche, NG Rouphael, DJ Diemert, AR Falsey, C Losada, LR Baden, ...
MedRxiv, 2022.07. 12.22277336, 2022
342022
HELZ2 is an IFN effector mediating suppression of dengue virus
DN Fusco, H Pratt, T Satoh
Frontiers in microbiology 8, 238546, 2017
342017
The system can't perform the operation now. Try again later.
Articles 1–20